Methadone maintenance treatment: The need to distinguish between holding dose, dose adequacy, satisfaction with methadone as a medication, and satisfaction with treatment

Journal of Clinical Psychopharmacology

Volumn 30, Issue 1, 2010, Pages 95-96

  Trujols, Joan ^a   Siñol, Núria ^a   De Los Cobos, José Pérez ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

DAILY LIFE ACTIVITY; DRUG EFFICACY; HEROIN DEPENDENCE; HUMAN; LETTER; METHADONE TREATMENT; OPIATE ADDICTION; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE;

DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DUAL (PSYCHIATRY); DRUG ADMINISTRATION SCHEDULE; HUMANS; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; PATIENT SATISFACTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 74549184499     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181c8b439     Document Type: Letter

References (10)

1. Elkader AK, Brands B, Dunn E, et al. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients. J Clin Psychopharmacol. 2009;29(1):77-81.
2. Hiltunen AJ, Beck O, Hjemdahl P, et al. Rated well-being in relation to plasma concentrations of L-and D-methadone in satisfied and dissatisfied patients on methadone maintenance treatment. Psychopharmacology (Berl). 1999;143(4):385-393.
3. Dyer KR, White JM. Patterns of symptom complaints in methadone maintenance patients. Addiction. 1997;92(11):1445-1455.
4. González-Saiz F. Opiate Dosage Adequacy Scale (ODAS): a clinical diagnostic tool as a guide to dosing decisions. Heroin Addict Relat Clin Probl. 2004;6(3):41-50.
5. González-Saiz F, Lozano Rojas O, Ballesta Gómez R, et al. Evidence of reliability and validity of the Opiate Dosage Adequacy Scale (ODAS) in a sample of methadone maintenance patients. Heroin Addict Relat Clin Probl. 2008;10(1):25-38.
6. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health. 2004;7(2):204-215.
7. Atkinson MJ, Kumar R, Cappelleri JC, et al. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. V a lu e H e a lt h. 2005;8(suppl 1):s9-s24.
8. Ruiz MA, Pardo A, Rejas J, et al. Development and validation of the BTreatment Satisfaction with Medicines Questionnaire[(SATMED-Q). Value Health. 2008;11(5):913-926
9. Pérez de los Cobos J, Siñol N, Trujols J, et al. Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment. Drug Alcohol Depend. 2007;89(2-3):190-194.
10. Pérez de Los Cobos J, Trujols J, Valderrama JC, et al. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment. Drug Alcohol Depend. 2005;79(3):405-412.